rxstat › Shortages › Ramipril

Ramipril (Altace) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 29, 2026

Some Ramipril products are in shortage in Canada (13 of 53 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 14, 2026.

An ACE inhibitor used to lower blood pressure and treat heart failure.

Products affected
13 / 53
In shortage since
Aug 15, 2018
Est. full return
Aug 14, 2026
Reports on file
230
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TARO-RAMIPRIL
10MG · CAPSULE · SUN PHARMA CANADA INC
DIN 02310546 · since Dec 3, 2025, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-RAMIPRIL
2.5MG · CAPSULE · APOTEX INC
DIN 02251531 · since Jun 16, 2026, est. end Aug 14, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-RAMIPRIL
5MG · CAPSULE · APOTEX INC
DIN 02251574 · since Jun 9, 2026, est. end Jul 3, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-RAMIPRIL
2.5MG · CAPSULE · APOTEX INC
DIN 02251531 · since Mar 17, 2026, est. end May 29, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-RAMIPRIL
5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02247946 · since Mar 12, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-RAMIPRIL
2.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02247945 · since Nov 19, 2025, no end estimate · Discontinued
Active shortage
TEVA-RAMIPRIL
10MG · CAPSULE · TEVA CANADA LIMITED
DIN 02247947 · since Nov 12, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-RAMIPRIL
10MG · CAPSULE · APOTEX INC
DIN 02251582 · since Feb 3, 2026, est. end May 1, 2026 · Disruption of the manufacture of the drug.
Active shortage
RAMIPRIL
10MG · CAPSULE · SANIS HEALTH INC
DIN 02374862 · since Jan 1, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RAMIPRIL
2.5MG · CAPSULE · SANIS HEALTH INC
DIN 02374846 · since Dec 8, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RAMIPRIL
5MG · CAPSULE · SANIS HEALTH INC
DIN 02374854 · since Dec 8, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP-RAMIPRIL
15MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02440334 · since Oct 1, 2020, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Ramipril is currently affected by 13 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC, APOTEX INC, TEVA CANADA LIMITED, SANIS HEALTH INC and 2 others.

The reported causes are: disruption of the manufacture of the drug; discontinued; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ramipril is classified under “ACE INHIBITORS, PLAIN” (ATC C09AA).

Recent changes

Common questions

What is Ramipril used for?

An ACE inhibitor used to lower blood pressure and treat heart failure.

When will Ramipril be back in stock in Canada?

The latest manufacturer estimate is Aug 14, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ramipril in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (ace inhibitors, plain)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Fosinopril No current shortage Benazepril (Lotensin) Partial shortage 1 of 5 reported products affected · est. return Aug 7, 2026 Cilazapril (Inhibace) Partial shortage 2 of 13 reported products affected · est. return Aug 11, 2026 Enalapril (Vasotec) Partial shortage 1 of 30 reported products affected · est. return Oct 9, 2026 Enalaprilat Partial shortage 1 of 1 reported products affected · est. return Aug 21, 2026 Lisinopril (Zestril) Partial shortage 6 of 39 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.